Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePRNewsWire • 06/14/24
Novavax, Inc. (NVAX) Jefferies 2024 Global Healthcare Conference (Transcript)Seeking Alpha • 06/09/24
FDA Panel to Consider Updating COVID-19 Jabs for New Virus StrainsZacks Investment Research • 06/04/24